Berk J L
Surg Clin North Am. 1975 Jun;55(3):721-8. doi: 10.1016/s0039-6109(16)40645-6.
The effective use of vasoactive drugs in shock requires an understanding of the pathophysiologic mechanisms involved in the various types and stages of shock and knowledge of the specific pharmacologic effects of each drug in the abnormal state. Vasoactive drugs should be used after the primary and secondary causes of shock have been corrected. Specific vasoactive drugs should be selected on the basis of measured hemodynamic abnormalities.
在休克中有效使用血管活性药物需要了解各种类型和阶段休克所涉及的病理生理机制,以及每种药物在异常状态下的具体药理作用。血管活性药物应在休克的主要和次要原因得到纠正后使用。应根据测得的血流动力学异常情况选择特定的血管活性药物。